AIMCA
MCRB icon

Alberta Investment Management Corp (AIMCo)’s Seres Therapeutics MCRB Stock Holding History

Alberta Investment Management Corp (AIMCo)’s Portfolio MCRB Stock Details MCRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-610
Closed -$84K – 979
2019
Q1 		$84K Buy
+610
New +$74.4K ﹤0.01% 883
2017
Q1 		– Sell
-575
Closed -$114K – 862
2016
Q4 		$114K Buy
+575
New +$125K ﹤0.01% 695

Other funds holding MCRB

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

Alberta Investment Management Corp (AIMCo)'s MCRB Position: Q2 2019 in Review

Alberta Investment Management Corp (AIMCo) sold out of Seres Therapeutics (MCRB) in Q2 2019, closing a stake of 610 shares — an estimated $84K sold.

Alberta Investment Management Corp (AIMCo) first reported a position in MCRB in Q4 2016 and held it in 2 quarters. The position peaked at $114K in Q4 2016. 91 funds tracked by Wall St. Rank hold MCRB as of Q2 2019.

  • Alberta Investment Management Corp (AIMCo) reported no remaining Seres Therapeutics position as of Q2 2019 after selling out during the quarter.
  • Alberta Investment Management Corp (AIMCo) sold 610 Seres Therapeutics shares in Q2 2019, an estimated $84K.
  • Alberta Investment Management Corp (AIMCo) first reported a position in Seres Therapeutics in Q4 2016 and held it in 2 quarters.
  • Alberta Investment Management Corp (AIMCo)'s Seres Therapeutics position peaked at $114K in Q4 2016.
  • 91 funds tracked by Wall St. Rank held Seres Therapeutics as of Q2 2019.

Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q2 2019, filed 14 Aug 2019.